×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
PPBT – purple biotech ltd. - american depositary shares (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
PPBT
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
11/15
03:26 pm
ppbt
Purple Biotech Ltd (NASDAQ: PPBT) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $33.00 price target on the stock.
Low
Report
Purple Biotech Ltd (NASDAQ: PPBT) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $33.00 price target on the stock.
11/15
07:06 am
ppbt
Purple Biotech Reports Third Quarter 2024 Financial Results [Yahoo! Finance]
Low
Report
Purple Biotech Reports Third Quarter 2024 Financial Results [Yahoo! Finance]
11/15
07:00 am
ppbt
Purple Biotech Reports Third Quarter 2024 Financial Results
Low
Report
Purple Biotech Reports Third Quarter 2024 Financial Results
11/4
07:50 am
ppbt
Purple Biotech Identifies Potential New Serum Biomarker for its Lead Oncology Therapeutic Candidate CM24: Associated with 79% Reduction in Risk of Death
Medium
Report
Purple Biotech Identifies Potential New Serum Biomarker for its Lead Oncology Therapeutic Candidate CM24: Associated with 79% Reduction in Risk of Death
10/25
07:20 am
ppbt
Purple Biotech Presents New Data for its Novel Tri-Specific T Cell and NK Cell Engagers Antibody Platform, CAPTN-3, at the EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics
Medium
Report
Purple Biotech Presents New Data for its Novel Tri-Specific T Cell and NK Cell Engagers Antibody Platform, CAPTN-3, at the EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics
10/10
07:30 am
ppbt
Purple Biotech to Present Data for its Tri-Specific Antibody Platform—CAPTN-3—at the EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics
Medium
Report
Purple Biotech to Present Data for its Tri-Specific Antibody Platform—CAPTN-3—at the EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics
9/20
02:17 pm
ppbt
Purple Biotech Ltd (NASDAQ: PPBT) had its price target raised by analysts at HC Wainwright from $8.00 to $33.00. They now have a "buy" rating on the stock.
Low
Report
Purple Biotech Ltd (NASDAQ: PPBT) had its price target raised by analysts at HC Wainwright from $8.00 to $33.00. They now have a "buy" rating on the stock.
9/18
06:30 am
ppbt
Purple Biotech Reports Additional Positive Interim Data from its Randomized Phase 2 Study with its Lead Oncology Therapeutic Candidate CM24
Medium
Report
Purple Biotech Reports Additional Positive Interim Data from its Randomized Phase 2 Study with its Lead Oncology Therapeutic Candidate CM24
Date
Time
Symbol
Company Name
Action
%Chg
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
11/15
07:06 am
ppbt
Form 6-K PURPLE BIOTECH LTD. For: Nov 15
Low
Report
Form 6-K PURPLE BIOTECH LTD. For: Nov 15
11/14
05:21 pm
ppbt
Form SC 13G/A PURPLE BIOTECH LTD. Filed by: ARMISTICE CAPITAL, LLC
Medium
Report
Form SC 13G/A PURPLE BIOTECH LTD. Filed by: ARMISTICE CAPITAL, LLC
11/4
07:51 am
ppbt
Form 6-K PURPLE BIOTECH LTD. For: Nov 04
High
Report
Form 6-K PURPLE BIOTECH LTD. For: Nov 04
10/25
07:21 am
ppbt
Form 6-K PURPLE BIOTECH LTD. For: Oct 25
Medium
Report
Form 6-K PURPLE BIOTECH LTD. For: Oct 25
10/10
07:40 am
ppbt
Form 6-K PURPLE BIOTECH LTD. For: Oct 10
Medium
Report
Form 6-K PURPLE BIOTECH LTD. For: Oct 10
10/9
07:41 am
ppbt
Form 6-K PURPLE BIOTECH LTD. For: Oct 09
Low
Report
Form 6-K PURPLE BIOTECH LTD. For: Oct 09
10/2
04:00 pm
ppbt
Form 6-K PURPLE BIOTECH LTD. For: Oct 02
Medium
Report
Form 6-K PURPLE BIOTECH LTD. For: Oct 02
9/18
06:32 am
ppbt
Form 6-K PURPLE BIOTECH LTD. For: Sep 18
High
Report
Form 6-K PURPLE BIOTECH LTD. For: Sep 18
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
TOP News Decliners
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: